Document Detail

A diagnostically difficult case of chronic myeloid neoplasm with eosinophilia and abnormalities of PDGFRA effectively treated with imatinib in accelerated phase: case report.
MedLine Citation:
PMID:  20010473     Owner:  NLM     Status:  MEDLINE    
Chronic myeloid neoplasm with eosinophilia and abnormalities of platelet-derived growth factor receptor alpha (PDGFRA), referred to until 2008 as chronic eosinophilic leukemia, is distinguished from hypereosinophilic syndrome (HES), if accompanied by genetic abnormalities that enable to determine eosinophil clonality. Typically, HES has a benign course and glucocorticosteroids suffice to achieve remission. In chronic myeloid neoplasm with eosinophilia and abnormalities of PDGFRA the FIP1L1-PDGFRA fusion gene can be detected. Its product is a protein showing tyrosine kinase activity leading to malignant proliferation of eosinophil precursors. Differential diagnosis of HES is often difficult because hypereosinophilia may also be reactive and may occur in many nonhematological as well as hematological disorders. Thus, reverse-transcription polymerase chain reaction (RT-PCR)is indicated in all patients with HES in order to detect the FIP1L1-PDGFRA transcript. Traditional treatment of chronic myeloid neoplasm with cytostatic drugs results in a short-term and transient remission or stabilization of the disease. We present the case of a 52-year-old patient with chronic myeloid neoplasm with eosinophilia and abnormalities of PDGFRA, in whom acceleration occurred after a year of cytostatic therapy with hydroxyurea and was successfully treated with imatinib. It was impossible to unequivocally determine the type of bone marrow disease based on histologic criteria, and a wide spectrum of molecular tests differentiating the type of myeloid proliferation were necessary to establish the diagnosis. RT-PCR did not reveal BCR-ABL or JAK2 V617F mutation. Further molecular testing showed rearrangement involving the FIP1L1 gene, thus enabling implementation of targeted therapy.
Marek Rodzaj; Krystyna Ga?azka; Miros?aw Majewski; Andrzej Zdu?czyk
Related Documents :
7271583 - Oncocytic lesions of the larynx.
9049863 - Late sequelae of treated pleomorphic xanthoastrocytoma: malignant brain stem astrocytom...
24299993 - Imaging of rathke's cleft cysts: criteria for a differential diagnosis.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Polskie Archiwum Medycyny Wewn?trznej     Volume:  119     ISSN:  1897-9483     ISO Abbreviation:  Pol. Arch. Med. Wewn.     Publication Date:  2009 Dec 
Date Detail:
Created Date:  2009-12-17     Completed Date:  2010-05-06     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0401225     Medline TA:  Pol Arch Med Wewn     Country:  Poland    
Other Details:
Languages:  eng     Pagination:  838-41     Citation Subset:  IM    
Department of Hematology and Internal Diseases, Rydygier Hospital, Krak?w, Poland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antineoplastic Agents / administration & dosage
Disease Progression
Gene Rearrangement
Hypereosinophilic Syndrome / diagnosis*,  drug therapy*,  genetics
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / diagnosis*,  drug therapy*,  genetics
Middle Aged
Oncogene Proteins, Fusion / metabolism*
Piperazines / administration & dosage*
Protein Kinase Inhibitors / administration & dosage
Pyrimidines / administration & dosage*
Receptor, Platelet-Derived Growth Factor alpha / metabolism*
mRNA Cleavage and Polyadenylation Factors / metabolism*
Reg. No./Substance:
0/Antineoplastic Agents; 0/FIP1L1-PDGFRA fusion protein, human; 0/Oncogene Proteins, Fusion; 0/Piperazines; 0/Protein Kinase Inhibitors; 0/Pyrimidines; 0/mRNA Cleavage and Polyadenylation Factors; 152459-95-5/imatinib; EC, Platelet-Derived Growth Factor alpha

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Peritoneal dialysis as a therapeutic approach in congestive heart failure resistant to pharmacologic...
Next Document:  Oral signs in the diagnosis of celiac disease: review of the literature.